Atea Pharmaceuticals Inc (AVIR) stock is lower by -74.81% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives AVIR stock a score of 24 out of a possible 100. That rank is mainly influenced by a long-term technical score of 1. AVIR's rank also includes a short-term technical score of 8. The fundamental score for AVIR is 62. In addition to the average rating from Wall Street analysts, AVIR stock has a mean target price of $13.67. This means analysts expect the stock to rise 49.85% over the next 12 months.
AVIR has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on AVIR!